Shire plc (Nasdaq; SHPG) is said to have pursued a number of deals before disclosure of an approach by AbbVie (NYSE: ABBV).
CEO Flemming Ornskov told the WSJ that AbbVie's offer "stopped us in our tracks."
Ornskov said "there were a number of large opportunities that we were considering, pursuing, preparing for, or engaging in" prior to AbbVie's offer.
Help employers find you! Check out all the jobs and post your resume.
